The demand must be insane.
I wonder if the issues fulfilling the orders of the actual drug product or the overly complex (and highly wasteful) drug delivery mechanism.?
Unlike Eli Lilly (who use chemical synthesis for Zepbound) they use yeast for synthesis and have decided not to contract out production to protect manufacturing trade secrets which makes ramping up slower, have to wait for their Denmark plant upgrade to come online.
The problem at the core is not like the shortages we have in Germany for basic stuff like general fever and pain medication, that's usually due to other countries just bidding more... for Ozempic, it's that virtually every single person gets blasted with joyful weight loss stories by influencers, demand for it is insane, and Novo Nordisk can't keep up with manufacturing despite the growth of the company being enough to account for the economic growth of the entire country of Denmark [2].
[1] https://en.wikipedia.org/wiki/Semaglutide#Generics
[2] https://www.abc.net.au/news/2023-12-19/ozempic-obesity-diabe...
> One of the conditions of section 503A restricts compounded drugs that are essentially copies of commercially available drugs, but FDA does not consider a drug to be commercially available when it appears on FDA’s drug shortages list.
I know for a fact you can obtain compounded semaglutide.